Jefferies Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $796K | Buy |
+3,300
| New | +$796K | 0.01% | 572 |
|
|
2025
Q1 | – | Sell |
-1,807
| Closed | -$594K | – | 1355 |
|
|
2024
Q4 | $594K | Sell |
1,807
-5,258
| -74% | -$1.73M | ﹤0.01% | 810 |
|
|
2024
Q3 | $2.36M | Buy |
+7,065
| New | +$2.36M | 0.02% | 381 |
|
|
2024
Q2 | – | Sell |
-695
| Closed | -$240K | – | 1133 |
|
|
2024
Q1 | $240K | Sell |
695
-1,305
| -65% | -$451K | ﹤0.01% | 978 |
|
|
2023
Q4 | $646K | Buy |
2,000
+1,265
| +172% | +$408K | ﹤0.01% | 774 |
|
|
2023
Q3 | $263K | Sell |
735
-200
| -21% | -$71.7K | ﹤0.01% | 866 |
|
|
2023
Q2 | $354K | Sell |
935
-9,065
| -91% | -$3.44M | ﹤0.01% | 864 |
|
|
2023
Q1 | $4.79M | Sell |
10,000
-6,527
| -39% | -$3.13M | 0.04% | 187 |
|
|
2022
Q4 | $6.95M | Buy |
+16,527
| New | +$6.95M | 0.05% | 141 |
|